A/Prof James Yip is currently a Senior Consultant Cardiologist in Cardiac Department of National University Heart Centre Singapore. He also holds the position of Chief Medical Information Officer in NUHS, Programme Director for Congenital/ Structural Heart Disease in NUHCS and is a Senior Clinical Lecturer of the Department of Medicine in Yong Loo Lin School of Medicine in NUS.
A/Prof James Yip graduated from the National University of Singapore in 1991 and has been a Fellow of the Academy of Medicine Singapore since 2001. He was trained in adult cardiology at the National University Hospital in Singapore from 1995 to 2001, and was a clinical fellow at Toronto Congenital Cardiac Centre for Adults from 2001 to 2002.
He is currently the Director of the Adult Congenital Heart Programme at NUHCS in Singapore. His interests include pregnancy and heart disease, pulmonary hypertension, Marfan syndrome and medical informatics.
Specialty Interest(s):
|
Pregnancy in Heart Disease
Medical Informatics |
Adult Congenital Heart Disease Programme
Cardiac Computed Tomographic Angiogrpahy |
Specializes in Diseases and Conditions:
|
Marfan syndrome
Pulmonary Hypertension |
Publications:
1. Echocardiographic left ventricular mass in a multiethnic Southeast Asian population: proposed new gender and age-specific norms. Wong RC, Yip JW, Gupta A, Yang H, Ling LH. Echocardiography. 2008 Sep;25(8):805-11.
2. Clinically compressed digital echocardiography: a patient-safe alternative to videotape review. Poh KK, Yang H, Omar AR, Yip JW, Chan YH, Ling LH. Ann Acad Med Singapore. 2007 Aug;36(8):662-71.
3. Noncompaction cardiomyopathy presenting with congestive heart failure during intercurrent dengue viral illness: importance of phenotypic recognition. Neo HY, Wong RC, Seto KY, Yip JW, Yang H, Ling LH. Int J Cardiol. 2006 Feb 8;107(1):123-5. No abstract available.
4. Extrinsic compression of the left main coronary artery. Ng MB, Chan M, Yip JW. Eur Heart J. 2005 Nov;26(22):2367. No abstract available.
5. ReoPro Observational Registry (RAPOR): insights from the multicentre use of abciximab in Asia. Poh KK, Tan HC, Yip JW, Lim YT. Singapore Med J. 2005 Aug;46(8):407-13.
Back to Top |
